戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 action produces soluble endoglin, we treated trophoblastic BeWo cells with either a broad-spectrum MM
2 d immunosorbent assay in the supernatants of trophoblastic cell cultures.
3 f giant syncytia, and that fusion of a human trophoblastic cell line expressing endogenous syncytin c
4         HIP supports attachment of the human trophoblastic cell line, JAR, in a HS-dependent fashion.
5 ellular Ca handling was investigated using a trophoblastic cell line, Rcho-1, derived from a rat chor
6  blastocysts to uterine epithelium and human trophoblastic cell lines to uterine epithelial cell line
7 he rat choriocarcinoma cell line Rcho-1 as a trophoblastic cell model system.
8 n that mediates apical cell adhesion between trophoblastic cells and luminal epithelial cells of the
9 n of single chain urokinase binding to human trophoblastic cells by long chain fatty acids was dose-d
10 Our results demonstrate that transduction of trophoblastic cells by the herpes simplex virus vector,
11 4% of cases, whereas the normal extravillous trophoblastic cells did not.
12  high basal expression of CYP27B1 and VDR in trophoblastic cells from the placenta, we hypothesized t
13 pression and enhanced lymphocyte adhesion to trophoblastic cells in experimental systems.
14 nal albumin endocytosis, was associated with trophoblastic cells in the interphase labyrinth.
15                                  In general, trophoblastic cells of HIV-positive placentas expressed
16 h levels were observed only in proliferating trophoblastic cells of the placenta and in adrenal gland
17 mpound had any effect on normal extravillous trophoblastic cells or JEG-3 cells.
18 ransfer of the lacZ reporter gene into human trophoblastic cells using herpes simplex virus and adeno
19 t inefficient transduction of differentiated trophoblastic cells with HSV.CMVlac is because of dimini
20 opin hormone (CSH) produced by the placental trophoblastic cells.
21 arcinoma JEG-3 cells and normal extravillous trophoblastic cells.
22 IV gag transcripts of HIV-positive placental trophoblastic cells.
23 se to proliferative stem cells with enhanced trophoblastic characteristics.
24  vivo studies using placentas -/- for fetal (trophoblastic) Cyp27b1 or VDR.
25 e placental syncytiotrophoblast and deported trophoblastic debris serve as sources of fetal mHAgs.
26 (TS) cell self-renewal, and promotes further trophoblastic differentiation both upstream and independ
27                                  Gestational trophoblastic disease (GTD) is a spectrum of rare neopla
28 noma, the most malignant form of gestational trophoblastic disease (GTD).
29 otherapy to eliminate persistent gestational trophoblastic disease (pGTD) was required in three of 19
30 ise strategies for management of gestational trophoblastic disease and address some of the controvers
31 astic tumours are a rare form of gestational trophoblastic disease and consequently information about
32                                  Gestational trophoblastic disease encompasses a range of pregnancy-r
33  of 631 patients who underwent treatment for trophoblastic disease had or developed evidence of brain
34 5 550 women were registered with gestational trophoblastic disease in the UK (1976-2006), of whom 62
35  Indications for chemotherapy in gestational trophoblastic disease include raised human chorionic gon
36                                  Gestational trophoblastic disease metastatic to the brain is curable
37 resents the malignant end of the gestational trophoblastic disease spectrum.
38 ly lower levels of expression in gestational trophoblastic disease tissues, particularly in complete
39 ics, diagnosis, and treatment of gestational trophoblastic disease.
40                                  Gestational trophoblastic diseases comprise a spectrum of interrelat
41 rtant role in the development of gestational trophoblastic diseases.
42                                The placental trophoblastic epithelium functions to transport nutrient
43 on can divert ES cells toward extraembryonic trophoblastic fates and implicate Ras-MAPK signaling in
44 ing the differentiation of Rcho-1 cells into trophoblastic giant cells supports the importance of CaB
45 thologic tissue-remodeling processes such as trophoblastic implantation, wound healing, and tumor inv
46 trium, whereas syncytiotrophoblasts covering trophoblastic lacunae or newly formed chorionic villi re
47                                          The trophoblastic layers of sos1(-/-) embryos were poorly de
48 ife-threatening complications of gestational trophoblastic neoplasia (four of 15 vs none of 36; p=0.0
49 logy and Obstetrics score >/= 7) gestational trophoblastic neoplasia (GTN) frequently receive etoposi
50          Treatment of persistent gestational trophoblastic neoplasia (GTN) has been one of the succes
51 All women should be screened for gestational trophoblastic neoplasia after termination of pregnancy.
52      Although most patients with gestational trophoblastic neoplasia are cured by chemotherapy and tu
53 eed, most patients with low-risk gestational trophoblastic neoplasia are treated with single agent ch
54 with a pathological diagnosis of gestational trophoblastic neoplasia at the time of their pregnancy t
55 Until the fundamental biology of gestational trophoblastic neoplasia becomes more clearly understood,
56                                  Gestational trophoblastic neoplasia comprises a unique group of huma
57                     Prognosis in gestational trophoblastic neoplasia is now excellent following treat
58 evelopments in the management of gestational trophoblastic neoplasia over the past few years.
59                                  Gestational trophoblastic neoplasia represents the malignant end of
60  and molar placentas, as well as gestational trophoblastic neoplasia, and assessed the effects of a n
61 or metastatic and chemoresistant gestational trophoblastic neoplasia.
62 utic targets to treat metastatic gestational trophoblastic neoplasia.
63 enetic changes that give rise to gestational trophoblastic neoplasia.
64 often not routinely examined for gestational trophoblastic neoplasia.
65  is expressed in the majority of gestational trophoblastic neoplasias, and is essential for choriocar
66  studies, but direct molecular evidence of a trophoblastic origin has not been established.
67 is in an attempt to confirm their presumable trophoblastic origin.
68 ithelioid trophoblastic tumors are of fetal (trophoblastic) origin.
69 tified gene regulatory networks for a set of trophoblastic proteins found to be differentially expres
70 ophinin, tastin, and cytokeratins in a human trophoblastic teratocarcinoma cell, HT-H.
71  trophoblast, IDO is not expressed in murine trophoblastic tissue but instead is found in stromal cel
72 te hydatidiform mole in which extraembryonic trophoblastic tissue develops but the embryo itself suff
73  in the invasive trophoblasts of gestational trophoblastic tissue.
74 n neoplastic diseases that derive from fetal trophoblastic tissues and represent semiallografts in pa
75                               Placental site trophoblastic tumor (PSTT) is a gestational neoplasm der
76 en treated with chemotherapy for gestational trophoblastic tumors (GTT).
77 c tumors (n = 20), and 60% of placental site trophoblastic tumors (n = 10) exhibited FASN positivity.
78 horiocarcinomas (n = 33), 90% of epithelioid trophoblastic tumors (n = 20), and 60% of placental site
79   Genetic analysis identified nongestational trophoblastic tumors (nGTTs).
80                               Placental site trophoblastic tumors and epithelioid trophoblastic tumor
81 first molecular evidence that placental site trophoblastic tumors and epithelioid trophoblastic tumor
82 al site trophoblastic tumors and epithelioid trophoblastic tumors are of fetal (trophoblastic) origin
83 al site trophoblastic tumors and epithelioid trophoblastic tumors are thought to arise from intermedi
84                                              Trophoblastic tumors represent a unique group of human n
85                                   All of the trophoblastic tumors were heterozygous in at least 1 of
86 ncer risks for patients cured of gestational trophoblastic tumors with modern chemotherapy appear sim
87  composed of choriocarcinoma, placental-site trophoblastic tumour, and epithelioid trophoblastic tumo
88 l-site trophoblastic tumour, and epithelioid trophoblastic tumour, and many forms are derived from th
89 choriocarcinoma, and the rare placental-site trophoblastic tumour.
90 f whom 62 were diagnosed with placental-site trophoblastic tumours and included, retrospectively, in
91                               Placental-site trophoblastic tumours are a rare form of gestational tro
92 These malignant forms are termed gestational trophoblastic tumours or neoplasia.
93 ffectiveness of treatment for placental-site trophoblastic tumours.
94 ression were observed with placentas -/- for trophoblastic VDR.
95 these separated blastomeres can become small trophoblastic vesicles, which in turn induce decidual re
96 and immunohistochemistry localized CYP2J2 in trophoblastic villi and deciduas at 12 weeks and term.
97              These data indicate that fetal (trophoblastic) vitamin D plays a pivotal role in control

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。